Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IL6ST divergent transcript (IL6ST-DT), also known as CTD-2031P19.3, is a long non-coding RNA gene transcribed from the region near the IL6ST (Interleukin 6 cytokine family signal transducer) gene on chromosome 5. This RNA is not translated into a protein, and currently there is no experimental evidence supporting a receptor or enzyme function, or direct relevance as a therapeutic target. Its biological role, if any, has not been characterized, and it does not interact with known drugs nor serve as a biomarker. It should not be confused with the protein-coding IL6ST gene (encoding gp130), which is an important cytokine receptor subunit involved in immune and inflammatory pathways.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IL6ST divergent transcript (IL6ST-DT).